Unknown

Dataset Information

0

Pharmacologic or genetic activation of SIRT1 attenuates the fat-induced decrease in beta-cell function in vivo.


ABSTRACT: BACKGROUND:There is evidence that sirtuin 1 (SIRT1), a key regulator of nutrient metabolism, increases ?-cell secretory function. Excess circulating fat, as seen in obesity, has been shown to decrease ?-cell function, an effect that may involve decreased SIRT1 activity. Consequently, SIRT1 activation may increase ?-cell function in conditions of elevated plasma-free fatty acid levels. Here we attempted to attenuate the lipid-induced decrease in ?-cell function in vivo using pharmacological and genetic models of SIRT1 activation. METHODS:Our pharmacologic model involved 48?h intravenous infusion of Wistar rats with either saline or oleate with or without the SIRT1 activator resveratrol. Additionally, we used ?-cell-specific SIRT1 overexpressing (BESTO) mice and wild-type littermates infused for 48?h intravenously with either saline or oleate. In both models, the infusion period was followed by assessment of ?-cell function using the hyperglycemic clamp method. RESULTS:Lipid infusion resulted in a significant decrease in ?-cell function as expected in both rats (p?

SUBMITTER: Desai T 

PROVIDER: S-EPMC6424971 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Pharmacologic or genetic activation of SIRT1 attenuates the fat-induced decrease in beta-cell function in vivo.

Desai Tejas T   Koulajian Khajag K   Ivovic Aleksandar A   Breen Danna M DM   Luu Lemieux L   Tsiani Evangelia L EL   Wheeler Michael B MB   Giacca Adria A  

Nutrition & diabetes 20190319 1


<h4>Background</h4>There is evidence that sirtuin 1 (SIRT1), a key regulator of nutrient metabolism, increases β-cell secretory function. Excess circulating fat, as seen in obesity, has been shown to decrease β-cell function, an effect that may involve decreased SIRT1 activity. Consequently, SIRT1 activation may increase β-cell function in conditions of elevated plasma-free fatty acid levels. Here we attempted to attenuate the lipid-induced decrease in β-cell function in vivo using pharmacologic  ...[more]

Similar Datasets

| S-EPMC5525071 | biostudies-other
| S-EPMC2216432 | biostudies-literature
| S-EPMC5161516 | biostudies-literature
| S-EPMC2655270 | biostudies-literature
| S-EPMC9685341 | biostudies-literature
2022-12-09 | GSE215410 | GEO
| S-EPMC4884130 | biostudies-literature
| S-EPMC5422577 | biostudies-literature
| S-EPMC2955293 | biostudies-literature
2009-05-01 | GSE15633 | GEO